Comparative Evaluation of the Effects of Different Doses of Labetalol on Cardiovascular Response to Tracheal Intubation

Document Type : Original Article (s)

Authors

1 Professor, Department of Anesthesiology, School of Medicine AND Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, School of Medicine AND Students Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

3 General Practitioner, Isfahan University of Medical Sciences, Isfahan, Iran

4 Representative of Anesthesiology, Kashani Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

AbstractBackground: This study aimed to determine the effects of different doses of labetalol on cardiovascular responses during tracheal intubation and to compare it with control group.Methods: In this study, 180 patients underwent surgery were selected and randomly divided in four groups who received 0.4, 1 and 2 mg/kg labetalol and normal saline via intravenous injection 5 minutes before laryngoscopy, respectively. The changes of hemodynamic parameters in four groups were compared.Findings: During the study, no patients in groups 0.4 and 1 mg/kg labetalol suffered from bradycardia; while in group of 2 mg/kg labetalol, at the time of laryngoscopy and at 1, 3, 5, 10, 30 and 60 minutes after it 13.3, 2.2, 11.1, 37.8, 28.9 and 24.4 percent of patients suffered from bradycardia, respectively; and in control group, 7 patients (15.6%) suffered from bradycardia. The incidence of bradycardia from 5th to 60th minutes was significantly different between the four groups (P < 0.05). No patient suffered from tachycardia among the groups receiving different doses of labetalol; while in control group, at the time of laryngoscopy and 1, 3, 5, and 10 minutes after it, 11.1, 40.0, 31.1, and 20.0 percent of the patients suffered from tachycardia, respectively (P < 0.05).Conclusion: Intravenous injection of 1 mg/kg labetalol during laryngoscopy tends to more favorable hemodynamic stability and minimal bradycardia, tachycardia and hypertension; using this dose before laryngoscopy is more favorable. 

Keywords

References

  1. Curry P, Viernes D, Sharma D. Perioperative management of traumatic brain injury. Int J Crit Illn Inj Sci 2011; 1(1): 27-35.
  2. Zygun DA, Steiner LA, Johnston AJ, Hutchinson PJ, Al-Rawi PG, Chatfield D, et al. Hyperglycemia and brain tissue pH after traumatic brain injury. Neurosurgery 2004; 55(4): 877-81.
  3. Hill J, Zhao J, Dash PK. High blood glucose does not adversely affect outcome in moderately brain-injured rodents. J Neurotrauma 2010; 27(8): 1439-48.
  4. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982; 32(11): 1239-46.
  5. Chung PC, Ng YT, Hsieh JR, Yang MW, Li AH. Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma. J Formos Med Assoc 2006; 105(3): 189-93.
  6. Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek JC, de Mena FT, Lopez JC. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2006; 128(1-2): 157-62.
  7. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993; 24(1): 111-6.
  8. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58(1): 47-50.
  9. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17(1): 107-24.
  10. Miller RD, Eriksson LI. Miller's anesthesia. Philadelphia, PA: Elsevier Health Sciences; 2009.
  11. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354(5): 449-61.
  12. Jabalameli M, Naghibi K, Sheibani S. Comparison of plasma glucose level among traumatic patients in casualty and emergency department. J Qazvin Univ Med Sci 2010; 14(2): 42-6. [In Persian].
  13. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56(5): 1058-62.
  14. Desai D, March R, Watters JM. Hyperglycemia after trauma increases with age. J Trauma 1989; 29(6): 719-23.
  15. Singh SP, Quadir A, Malhotra P. Comparison of esmolol and labetalol, in low doses, for attenuation of sympathomimetic response to laryngoscopy and intubation. Saudi J Anaesth 2010; 4(3): 163-8.
  16. Goldberg ME, McNulty S, Levette A, Goldman S. Intravenous labetalol for induced hypotension in an adult patient undergoing coarctation repair. J Cardio Anesthesia 1988; 2(5): 673-7.
  17. Roelofse JA, Shipton EA, Joubert JJ, Grotepass FW. A comparison of labetalol, acebutolol, and lidocaine for controlling the cardiovascular responses to endotracheal intubation for oral surgical procedures. J Oral Maxillofac Surg 1987; 45(10): 835-41.
  18. Inada E, Cullen DJ, Nemeskal AR, Teplick R. Effect of labetalol or lidocaine on the hemodynamic response to intubation: a controlled randomized double-blind study. J Clin Anesth 1989; 1(3): 207-13.
  19. Chung KS, Sinatra RS, Chung JH. The effect of an intermediate dose of labetalol on heart rate and blood pressure responses to laryngoscopy and intubation. J Clin Anesth 1992; 4(1): 11-5.
Journal of Isfahan Medical School
Volume 34, Issue 393 - Serial Number 393
July and August 2016
Pages 893-900

Files

History

  • Receive Date: 16 May 2016
  • Revise Date: 04 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics